No profile data available.
Petros Pharmaceuticals, Inc. (PTPI) is a healthcare company in the medical sector application systems industry, based in New York, United States, with about 3 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$43.69 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. UNITED STATES was its largest region in fiscal year 2024, with 79% of revenue. Its market capitalization was $127,116 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Petros Pharmaceuticals reported $0 in revenue for fiscal year 2025, down 100.0% from $5.11 million in fiscal year 2024. In Q1 2026 revenue was $0.
UNITED STATES: 79% of revenue by region in fiscal year 2024, followed by Non-US (21%).
$127,116 as of October 9, 2026.
Listed companies of a similar size in the same industry (medical sector application systems) include PPJ Healthcare Enterprises, Inc. (PPJE), Synbio International, Inc. (SYIN), ORHub, Inc. (ORHB), Holdco Nuvo Group D.G Ltd (NUVOQ).